Literature DB >> 11131380

Initial treatment of the early stages (I, II) of supraglottic squamous cell carcinoma: partial laryngectomy versus radiotherapy.

C Orús1, X León, M Vega, M Quer.   

Abstract

The purpose of this study was to define the treatment of choice (partial laryngectomy vs radiotherapy) in the early stage of supraglottic squamous cell cancer (ESSC). One hundred and fifteen patients with ESSC were treated with either partial laryngectomy (25 patients) or with radiotherapy(90 patients) between January 1984 and December 1996. All patients had a follow-up of over 29 months. Radiotherapy (RT) had a local control rate of 79%, which increased to 90% with salvage surgery, and a high larynx preservation rate (83%). Partial laryngectomy (PL) offered a better initial local control rate of 84%, which increased to 88% with salvage surgery, and functional results were also good (80%). No statistically significant differences were found between RT and PL. RT was less costly, showed better suitability for treatment, produced moderate morbidity and sequelae, and local recurrence was easier to rescue. However, it is a once-only application technique. PL showed higher immediate postoperative morbidity, higher cost and lower suitability for treatment but had fewer sequelae, offered the best initial local control and is multi-applicable. No clear oncological arguments were found in our series to define whether PL or RT is the treatment of choice for ESSC. Both are effective therapies. Secondary factors such as suitability for treatment, morbidity, cost and applicability should be individually evaluated when choosing the type of treatment. As the laser endoscopic approach decreases morbidity and costs and makes the condition more suitable for treatment, it could be the treatment of choice for ESSC, in cases where local tumoral extent and larynx exposure allow radical excision.

Entities:  

Mesh:

Year:  2000        PMID: 11131380     DOI: 10.1007/s004050000276

Source DB:  PubMed          Journal:  Eur Arch Otorhinolaryngol        ISSN: 0937-4477            Impact factor:   2.503


  9 in total

1.  Supraglottic laryngectomy: analysis of 267 cases.

Authors:  Maria Agustina Sevilla; Juan Pablo Rodrigo; José Luis Llorente; Rubén Cabanillas; Fernando López; Carlos Suárez
Journal:  Eur Arch Otorhinolaryngol       Date:  2007-08-08       Impact factor: 2.503

2.  Guidelines for the Surgical Management of Laryngeal Cancer: Korean Society of Thyroid-Head and Neck Surgery.

Authors:  Soon-Hyun Ahn; Hyun Jun Hong; Soon Young Kwon; Kee Hwan Kwon; Jong-Lyel Roh; Junsun Ryu; Jun Hee Park; Seung-Kuk Baek; Guk Haeng Lee; Sei Young Lee; Jin Choon Lee; Man Ki Chung; Young Hoon Joo; Yong Bae Ji; Jeong Hun Hah; Minsu Kwon; Young Min Park; Chang Myeon Song; Sung-Chan Shin; Chang Hwan Ryu; Doh Young Lee; Young Chan Lee; Jae Won Chang; Ha Min Jeong; Jae-Keun Cho; Wonjae Cha; Byung Joon Chun; Ik Joon Choi; Hyo Geun Choi; Kang Dae Lee
Journal:  Clin Exp Otorhinolaryngol       Date:  2017-01-03       Impact factor: 3.372

3.  Extended and standard supraglottic laryngectomies: a review of 110 patients.

Authors:  Jean-Michel Prades; Pierre-Gilles Simon; Andrei P Timoshenko; Jean-Marc Dumollard; Thierry Schmitt; Christian Martin
Journal:  Eur Arch Otorhinolaryngol       Date:  2005-11-19       Impact factor: 2.503

4.  Hypofractionation vs. conventional radiotherapy fractionation in the conservative treatment of T1 glottic cancer: a prospective cohort study.

Authors:  B G Salas-Salas; D J Domínguez-Nuez; R Cabrera; L Ferrera-Alayón; M Lloret; P C Lara
Journal:  Clin Transl Oncol       Date:  2019-06-01       Impact factor: 3.405

5.  Overexpression of human 27 kDa heat shock protein in laryngeal cancer cells confers chemoresistance associated with cell growth delay.

Authors:  Jung-Hee Lee; Dongil Sun; Kwang-Jae Cho; Min-Sik Kim; Myung-Hwa Hong; In-Kyung Kim; Jae-Seon Lee; Jeong-Hwa Lee
Journal:  J Cancer Res Clin Oncol       Date:  2006-08-12       Impact factor: 4.553

6.  [New aspects of primary radiochemotherapy in head and neck cancer. Highlights from the 2011 ASCO Congress].

Authors:  S Laban; C J Wang; R Knecht; S Tribius; A Münscher
Journal:  HNO       Date:  2012-05       Impact factor: 1.284

7.  Outcome after supracricoid laryngectomies in the material of ENT Department, Poznan University of Medical Sciences.

Authors:  Witold Szyfter; Małgorzata Leszczyńska; Małgorzata Wierzbicka
Journal:  Eur Arch Otorhinolaryngol       Date:  2011-02-09       Impact factor: 2.503

Review 8.  Treatment of early stage Supraglottic squamous cell carcinoma: meta-analysis comparing primary surgery versus primary radiotherapy.

Authors:  Krupal B Patel; Anthony C Nichols; Kevin Fung; John Yoo; S Danielle MacNeil
Journal:  J Otolaryngol Head Neck Surg       Date:  2018-03-05

9.  Traditional transcutaneous approaches in head and neck surgery.

Authors:  Ulrich R Goessler
Journal:  GMS Curr Top Otorhinolaryngol Head Neck Surg       Date:  2012-12-20
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.